Gastroenterology Learning Network

Dr Mark Pimentel, an expert in small intestinal bacterial overgrowth and intestinal methanogen overgrowth (IMO), provides an update on diagnosing and treating SIBO. The podcast covers the symptoms and diagnostic challenges of SIBO and IMO, the controversy surrounding gut microbiota testing, measuring hydrogen sulfide in breath tests, and the relationship between SIBO and IBS.

The podcast discusses the effectiveness of Upadacitinib therapy for Crohn's disease, highlighting its superior alternative to placebo. They review the trial results, efficacy, tolerability, and safety of the drug. The speakers also discuss treatment approaches for active IBD and spondyloarthropathy, as well as the potential benefits of jack inhibitors for pydderma. They touch on clinical trial results, dosing considerations, and conclude that the benefits of Upadacitinib outweigh the risks.

Dr. Adam Faye discusses the association between patient factors and postoperative complications in older patients with inflammatory bowel disease. Topics include: factors impacting 30-day outcomes, demographic differences in surgical outcomes, the importance of a multidisciplinary approach to preoperative care, and plans to expand the study on risk factors and surgical outcomes for older adults.

Dr Gil Melmed from Cedars-Sinai talks with Drs Raymond Cross and Millie Long about the importance of vaccines, cancer screenings, and other aspects of overall health maintenance for patients with inflammatory bowel disease.

IBD Drive Time: Christina Ha, MD, on Biosimilars by Gastroenterology Learning Network

Guest Christina Ha, MD, from the Mayo Clinic in Arizona, reviews key points about the advent of biosimilars, including reassuring patients and countering the "nocebo" effect, with hosts Drs Raymond Cross and Millie Long.

Experts in gastrointestinal disorders discuss their recently co-authored joint guideline on the pharmacological management of chronic constipation. The podcast explores the collaboration between leading gastrointestinal societies, the 10 recommendations made by the panel, the use of Lube Prostone for treating chronic constipation, the efficacy and dosing instructions of NACLA-TIDE and GCC agonists, and the importance of personalized management approaches.

In part 2 of their podcast on Helicobacter pylori, Drs William Chey and Brian Lacy talk about the risks of untreated disease and the various types of treatment available.

In this first of a two-part podcast on Helicobacter pylori, Drs Brian Lacy and William Chey discuss the prevalence of H pylori infection and how to best diagnose the condition.

Dr David Rubin discusses the obstacles in obtaining IBD therapies. Challenges include affordability, copay accumulators, and delays in prior authorization. Creative solutions like financial assistance and patient assistance programs are key. Advocacy efforts from state and national entities are needed to improve access to care.